Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune checkpoint inhibitors (ICIs) have emerged as a transformative therapeutic ...
The WVU Cancer Institute at United Hospital Center (UHC) is offering CYTALUX® (pafolacianine), a groundbreaking imaging agent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback